Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 14 February 2012
Vol. 5, Issue 211, p. ra13
[DOI: 10.1126/scisignal.2001963]


Editor's Summary

Biasing TLR4 Signaling Toward a Less Inflammatory Route
Signaling downstream of Toll-like receptor 4 (TLR4) proceeds through two pathways that are dependent on distinct adaptor proteins. One of these pathways leads to immunostimulatory responses, whereas the other leads to the production of toxic proinflammatory cytokines. Compounds that could stimulate the beneficial arm rather than the proinflammatory arm would be useful as adjuvants for vaccines. Bowen et al. investigated two synthetic TLR4 agonists that differed only in their stereochemistry at a single point in their structure and found that whereas one agonist stimulated both arms of the TLR4 pathway, the other agonist stimulated only the noninflammatory branch. These findings have implications for the design of more effective vaccine adjuvants.

Citation: W. S. Bowen, L. A. Minns, D. A. Johnson, T. C. Mitchell, M. M. Hutton, J. T. Evans, Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist. Sci. Signal. 5, ra13 (2012).

Read the Full Text

TLR4-mediated pro-inflammatory dendritic cell differentiation in humans requires the combined action of MyD88 and TRIF.
S. T. Kolanowski, M. C. Dieker, S. N. Lissenberg-Thunnissen, G. M. van Schijndel, S. M. van Ham, and A. t. Brinke (2014)
Innate Immunity 20, 423-430
   Abstract »    Full Text »    PDF »
Adjuvant Activity of Naturally Occurring Monophosphoryl Lipopolysaccharide Preparations from Mucosa-Associated Bacteria.
P. M. Chilton, D. M. Hadel, T. T. To, T. C. Mitchell, and R. P. Darveau (2013)
Infect. Immun. 81, 3317-3325
   Abstract »    Full Text »    PDF »
Src-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor-induced interleukin 12 synthesis.
M. Wolfl, S. Schwinn, Y.-E. Yoo, M. L. Ress, M. Braun, M. Chopra, S. C. Schreiber, V. I. Ayala, C. Ohlen, M. Eyrich, et al. (2013)
Blood 122, 1203-1213
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882